文献库搜索 | GeneLibs

Guan(J),Hu(J),Lin(S),Chen(C),Luo(Y),Zhou(W... BMC Res Notes 2026-04-20

...BRCA1 was detected in 3 cases, while pathogenic variants c.3109 C > T and c.8951 C > G in the BRCA2 were each detected i...

Stranne(J),Axen(E),Bratt(O),Carlsson(S),Ki... Scand J Urol 2026-04-21

...BRCA1/2-mutated disease. The Swedish guidelines 2025 provide a more comprehensive framework for rehabilitation and survi...

Le Bars(S),Guerin-Charbonnel(C),Martin(E),... Eur J Surg Oncol 2026-06-00

...BRCA1/2 deleterious mutation, LNR ≥25% vs none indicated a poorer prognosis for both overall survival (OS) (HR = 2.46 [1...

Kozan(EN),Delgado-de la Mora(J),Al Assaad(... Pathol Res Pract 2026-06-00

...BRCA1/2 wild-type and harbored deleterious structural variants in other homologous recombination repair genes. Therapeut...

Matkowski(R),Abrahamowska(M),Michalowska(D... BMC Cancer 2026-04-21

BACKGROUND: The prevalence and spectrum of pathogenic and likely pathogenic variants (PVs/LPVs) in BRCA1/2 vary across p...

Avila-Rodriguez(V),Ruiz-Patiño(A),Bonilla-... Case Rep Oncol Med None

...BRCA1, BRCA2, MLH1, MSH2, MSH6, PMS2, APC, TP53, PTEN, and STK11, conferring a higher risk of multiple primary malignanc...

Abdallah(ZA),Khamis(EA),Hendy(A),Abdelalie... Patient Educ Couns 2026-08-00

...BRCA1/2 genetic testing METHODS: A quasi-experimental pre-post study was conducted in the outpatient clinics of the Egyp...

Webber(JW),Wollborn(L),Mishra(S),Alimena(S... Sci Rep 2026-03-24

...BRCA1 and BRCA2. However, most women with HBOC are undiagnosed, and some patients meeting clinical criteria for HBOC wil...

Wichtowski(M),Adamska(M),Łojko-Dankowska(A... Breast Cancer (Dove Med Press) None

...BRCA1 negative) and successfully treated with breast-conserving therapy, adjuvant radiotherapy, and hormone therapy. Sev...

Tan(CJ),Willis(C),Au(T),Schabath(MB),Li(C)... JCO Precis Oncol 2026-03-00

...BRCA1 mutations (1.9% v 8.6%, P = .04) were less prevalent in the HER2-low subgroup compared with those with HER2 IHC 0 ...